Navigation Links
HIV 'Cure' Looks 'Promising,' Danish Scientists Contend
Date:4/29/2013

MONDAY, April 29 (HealthDay News) -- Danish scientists testing a novel HIV treatment in human trials contend that they're confident their strategy will result in a cure for the AIDS-causing virus, according to news reports.

The technique -- already tested successfully in lab experiments -- involves freeing the HIV virus from DNA cells, where it collects in "reservoirs," and bringing it to the surface of the cells, the Telegraph in Great Britain reported. Once the virus has surfaced, it can be permanently destroyed by a "vaccine" that primes the body's natural immune system, the researchers said.

"I am almost certain that we will be successful in releasing the reservoirs of HIV," said Dr. Ole Sogaard, a senior researcher at the Aarhus University Hospital in Denmark, according to the news report. So far the clinical trials are "promising," he said.

Human clinical trials are under way, said Sogaard, adding that early signs are "promising. I am almost certain that we will be successful in releasing the reservoirs of HIV," he said.

Fifteen patients are currently taking part in the trials, and if they are found to have successfully been cured of HIV, the "cure" will be tested on a wider scale, the Telegraph reported.

"The challenge will be getting the patients' immune system to recognize the virus and destroy it. This depends on the strength and sensitivity of individual immune systems," Sogaard said, the newspaper reported.

Sogaard said a "cure" is different than a preventative vaccine. That means continued awareness of unsafe behaviors -- such as avoiding unprotected sex or sharing needles for intravenous drug use -- is still the key to combating HIV.

If the Danish researchers are successful, it would obviously represent a huge step in the battle against HIV.

A large study of an experimental HIV vaccine was halted recently because the shots weren't preventing infection, the U.S. National Institutes of Health said last week.

The clinical trial included about 2,500 people, mostly gay men, in 19 cities. Half of the participants were given the vaccine developed by the NIH and half received placebo shots. A safety review found that slightly more people who had received the vaccine later became infected with HIV. The reasons for this aren't clear.

While the vaccinations are being stopped, the NIH said it will continue to track the study participants' health, the Associated Press reported.

Numerous attempts to develop an HIV/AIDS vaccine have failed.

More information

To learn more about HIV, visit the U.S. National Library of Medicine.

-- HealthDay staff

SOURCES: Telegraph, April 27, 2013; Associated Press


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Fish Pedicure a Recipe for Bacterial Infection, Researchers Warn
2. Arizona State University secures defense contract
3. Pornography and Masturbation Addiction Can Be Cured – Las Vegas Therapist Shares His Ideas
4. OnPage Provides Secure, Rapid Response at New England’s Largest Catholic Hospital
5. Prevention is better than cure for killer cardiovascular disease
6. Researchers develop secure protocol for linking data registries for HPV surveillance
7. 23andMe acquires CureTogether, Inc.
8. Clinical trial seeks to cure advanced Crohns disease using bone marrow transplant
9. Can gene therapy cure fatal diseases in children?
10. AACR, Komen for the Cure honor researcher with lecture on science of cancer health disparities
11. Many Mistakenly Think Radiation Might Cure Terminal Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV 'Cure' Looks 'Promising,' Danish Scientists Contend
(Date:5/4/2016)... ... , ... A new collaboration will give more researchers access to the largest ... analytics leader SAS will provide researchers worldwide with data management and analytics tools to ... , The DCRI and SAS share the goal of greater transparency and openness ...
(Date:5/4/2016)... ... May 04, 2016 , ... Slepkow Slepkow & ... one of the top website design companies to create a state of the ... to the law firm's main practice areas. These practice areas include: real estate, ...
(Date:5/4/2016)... ... May 04, 2016 , ... Francesca Loparco, Co-Founder of Queen City Dream Cars, ... same-day LASIK procedure at Christenbury Eye Center. The entrepreneur struggled with her ... surgery the same day as her in-office consultation and eye exam. Francesca’s eyesight was ...
(Date:5/4/2016)... ... 2016 , ... Advanced Spine & Sport Medical Rehabilitation Center, which is renowned ... a free seminar on stem cell injections. The seminar is scheduled for Wednesday, May ... Telephone Road, Suite 110, Ventura, CA. There are only 10 seats available. , ...
(Date:5/4/2016)... Lenexa, KS (PRWEB) , ... May 04, 2016 ... ... Transtem™ Patient 2016, a powerful cellular therapy software application that helps ... life-saving treatments to patients. , Since Transtem’s initial launch, Mediware has continued to ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Multiple Myeloma Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Multiple Myeloma epidemiology, Multiple Myeloma market valuations ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute lymphocytic Leukemia Market ... to their offering.       (Logo: ... Acute Lymphocytic Leukemia Market and Competitive Landscape ... Lymphocytic Leukemia pipeline products, Acute Lymphocytic Leukemia ...
(Date:5/3/2016)... , May 3, 2016  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further expand product ... Photo - http://photos.prnewswire.com/prnh/20160503/362921 ... ... ... ...
Breaking Medicine Technology: